Cargando…

Flow-oriented Venous Anastomosis to Control Lymph Flow of Lymphatic Malformation

Less-invasive surgeries, such as lymphaticovenular anastomosis (LVA), are the widely accepted intervention for lymphedema. This study aimed to assess the outcomes of flow-oriented LVA modification on lymphatic malformation (LM). METHODS: We included 19 patients diagnosed with LM mixed type or microc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Motoi, Watanabe, Shoji, Watanabe, Azusa, Iida, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952148/
https://www.ncbi.nlm.nih.gov/pubmed/31942325
http://dx.doi.org/10.1097/GOX.0000000000002199
_version_ 1783486396899524608
author Kato, Motoi
Watanabe, Shoji
Watanabe, Azusa
Iida, Takuya
author_facet Kato, Motoi
Watanabe, Shoji
Watanabe, Azusa
Iida, Takuya
author_sort Kato, Motoi
collection PubMed
description Less-invasive surgeries, such as lymphaticovenular anastomosis (LVA), are the widely accepted intervention for lymphedema. This study aimed to assess the outcomes of flow-oriented LVA modification on lymphatic malformation (LM). METHODS: We included 19 patients diagnosed with LM mixed type or microcystic type, who came to our clinic from June 2015 to December 2017. Under general anesthesia, all patients were administered an indocyanine green lymphography injection subcutaneously. In the case of a strong inflow, the patient underwent afferent lymph vessel of LM to venous anastomosis (LMVA). Otherwise, the side wall of LMVA was performed to the cysts. Outcomes were classified into the following groups based on the size changes: treatment effect (TE) 4 = >80% reduction rate; TE 3 = 50%–80% reduction rate; TE 2 = 20%–50% reduction rate; and TE 1 = 0%–20% reduction rate. RESULTS: All cases underwent surgery, with no case having an increased size. The results were as follows: TE 4 = 4 (21%) patients; TE 3 = 6 (32%) patients; TE 2 = 5 (26%) patients; and TE 1 = 4 (21%) patients. No case required study termination due to disease progression. Minor complication occurred in 3 cases. One vesicle increased at the labial mucosa and one wound dehiscence that epithelized within 1 month. CONCLUSION: LMVA could be a novel, minimally invasive lymph flow-oriented surgical method for intractable LM.
format Online
Article
Text
id pubmed-6952148
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-69521482020-01-15 Flow-oriented Venous Anastomosis to Control Lymph Flow of Lymphatic Malformation Kato, Motoi Watanabe, Shoji Watanabe, Azusa Iida, Takuya Plast Reconstr Surg Glob Open Original Article Less-invasive surgeries, such as lymphaticovenular anastomosis (LVA), are the widely accepted intervention for lymphedema. This study aimed to assess the outcomes of flow-oriented LVA modification on lymphatic malformation (LM). METHODS: We included 19 patients diagnosed with LM mixed type or microcystic type, who came to our clinic from June 2015 to December 2017. Under general anesthesia, all patients were administered an indocyanine green lymphography injection subcutaneously. In the case of a strong inflow, the patient underwent afferent lymph vessel of LM to venous anastomosis (LMVA). Otherwise, the side wall of LMVA was performed to the cysts. Outcomes were classified into the following groups based on the size changes: treatment effect (TE) 4 = >80% reduction rate; TE 3 = 50%–80% reduction rate; TE 2 = 20%–50% reduction rate; and TE 1 = 0%–20% reduction rate. RESULTS: All cases underwent surgery, with no case having an increased size. The results were as follows: TE 4 = 4 (21%) patients; TE 3 = 6 (32%) patients; TE 2 = 5 (26%) patients; and TE 1 = 4 (21%) patients. No case required study termination due to disease progression. Minor complication occurred in 3 cases. One vesicle increased at the labial mucosa and one wound dehiscence that epithelized within 1 month. CONCLUSION: LMVA could be a novel, minimally invasive lymph flow-oriented surgical method for intractable LM. Wolters Kluwer Health 2019-07-29 /pmc/articles/PMC6952148/ /pubmed/31942325 http://dx.doi.org/10.1097/GOX.0000000000002199 Text en Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Article
Kato, Motoi
Watanabe, Shoji
Watanabe, Azusa
Iida, Takuya
Flow-oriented Venous Anastomosis to Control Lymph Flow of Lymphatic Malformation
title Flow-oriented Venous Anastomosis to Control Lymph Flow of Lymphatic Malformation
title_full Flow-oriented Venous Anastomosis to Control Lymph Flow of Lymphatic Malformation
title_fullStr Flow-oriented Venous Anastomosis to Control Lymph Flow of Lymphatic Malformation
title_full_unstemmed Flow-oriented Venous Anastomosis to Control Lymph Flow of Lymphatic Malformation
title_short Flow-oriented Venous Anastomosis to Control Lymph Flow of Lymphatic Malformation
title_sort flow-oriented venous anastomosis to control lymph flow of lymphatic malformation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952148/
https://www.ncbi.nlm.nih.gov/pubmed/31942325
http://dx.doi.org/10.1097/GOX.0000000000002199
work_keys_str_mv AT katomotoi floworientedvenousanastomosistocontrollymphflowoflymphaticmalformation
AT watanabeshoji floworientedvenousanastomosistocontrollymphflowoflymphaticmalformation
AT watanabeazusa floworientedvenousanastomosistocontrollymphflowoflymphaticmalformation
AT iidatakuya floworientedvenousanastomosistocontrollymphflowoflymphaticmalformation